Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.

Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. J Infect Dis. 2009 Jul 15; 200(2):202-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.